Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AVGO
5. AAPL
6. ALNY
7. CNS
8. STLA
9. EC
10. SRE

Go back to Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
APTARGROUP, Inc. (NYSE: ATR) Delayed: 131.62 -1.37 (1.03%)
Previous Close $132.99    52 Week High $81.50 
Open $132.21    52 Week Low $66.33 
Day High $132.44    P/E 52.23 
Day Low $130.83    EPS $2.52 
Volume 389,240